Cargando…

Dry Age-Related Macular Degeneration: Distribution of Visual Acuity and Progression Risk in a Large Registry

INTRODUCTION: Understanding the progression to geographic atrophy (GA) in late dry age-related macular degeneration (dAMD) can support development opportunities for dAMD treatments. We characterized dAMD by distribution of visual acuity (VA) categories and evaluated VA progression risk by disease st...

Descripción completa

Detalles Bibliográficos
Autores principales:	Leng, Theodore, Schwartz, Jason, Nimke, David, Gallivan, Mark, Fevrier, Helene, Rozario, Nigel, Schultz, Neil M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Healthcare 2022
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9834463/ https://www.ncbi.nlm.nih.gov/pubmed/36369619 http://dx.doi.org/10.1007/s40123-022-00583-y

Ejemplares similares

Visual acuity loss associated with excessive “dry macula” in exudative age-related macular degeneration
por: Takahashi, Hidenori, et al.
Publicado: (2018)

Functional Visual Acuity in Age-Related Macular Degeneration
por: Tomita, Yohei, et al.
Publicado: (2016)

Photobiomodulation reduces drusen volume and improves visual acuity and contrast sensitivity in dry age‐related macular degeneration
por: Merry, Graham F., et al.
Publicado: (2016)

The Patient Experience: Symptoms and Impact of Dry Age-Related Macular Degeneration
por: Schultz, Neil M., et al.
Publicado: (2021)

Mental health and visual acuity in patients with age-related macular degeneration
por: Fonteh, Cheryl N., et al.
Publicado: (2022)

Relationships of orientation discrimination threshold and visual acuity with macular lesions in age-related macular degeneration
por: Fu, Haojie, et al.
Publicado: (2017)

Effect of Phacoemulsification on Visual Acuity and Macular Morphology in Patients with Wet Age-Related Macular Degeneration
por: Figurska, Małgorzata, et al.
Publicado: (2018)

Relevance of Visual Acuity Measurement for Therapeutic Decisions in Age-Related Macular Degeneration
por: Mathis, Thibaud, et al.
Publicado: (2023)

Baseline Predictors of Visual Acuity Outcome in Patients with Wet Age-Related Macular Degeneration
por: Zhang, Xinyuan, et al.
Publicado: (2018)

Bevacizumab Injection in Patients with Age-Related Macular Degeneration Associated with Poor Initial Visual Acuity
por: El Matri, Leila, et al.
Publicado: (2012)

Intravitreal treatment in patients with exudative age-related macular degeneration and visual acuity ≤ 0.05
por: Koch, Raphael, et al.
Publicado: (2015)

Predictors of Visual Acuity After Treatment of Neovascular Age-Related Macular Degeneration – Current Perspectives
por: Phan, Long T, et al.
Publicado: (2021)

Correlation of macular sensitivity measures and visual acuity to vision-related quality of life in patients with age-related macular degeneration
por: Forshaw, Thomas Richard Johansen, et al.
Publicado: (2021)

Changes in best-corrected visual acuity in patients with dry age-related macular degeneration after stem cell transplantation: systematic review and meta-analysis
por: Li, Licheng, et al.
Publicado: (2022)

The effects of ranibizumab injections on fluorescein angiographic findings and visual acuity recovery in age-related macular degeneration
por: Gungel, Hulya, et al.
Publicado: (2014)

Correlation of Baseline Visual Acuity with Outcomes of Treatment with Anti-VEGF in Neovascular Age-Related Macular Degeneration
por: Veluswamy, Balaji, et al.
Publicado: (2020)

Efficacy of a single injection of brolucizumab in neovascular age-related macular degeneration on visual acuity and micromorphometry
por: Joshi, Shrinivas, et al.
Publicado: (2023)

Distribution of macular pigments in macular telangiectasia type 2 and correlation with optical coherence tomography characteristics and visual acuity
por: Srinivasan, Ramyaa, et al.
Publicado: (2022)

Correlation of Central Versus Peripheral Macular Structure-Function With Acuity in Age-Related Macular Degeneration
por: Sabeti, Faran, et al.
Publicado: (2021)

Functional outcomes after multiple treatments with ranibizumab in neovascular age-related macular degeneration beyond visual acuity
por: Feigl, Beatrix, et al.
Publicado: (2007)

Benefits of aflibercept treatment for age-related macular degeneration patients with good best-corrected visual acuity at baseline
por: Minami, Sakiko, et al.
Publicado: (2018)

Foveal threshold and photoreceptor integrity for prediction of visual acuity after intravitreal aflibercept on age-related macular degeneration
por: Sakai, Tsutomu, et al.
Publicado: (2018)

Association between visual acuity, lesion activity markers and retreatment decisions in neovascular age-related macular degeneration
por: Chakravarthy, Usha, et al.
Publicado: (2020)

Five-Year Outcome of Aflibercept Monotherapy for Exudative Age-Related Macular Degeneration with Good Baseline Visual Acuity
por: Kikushima, Wataru, et al.
Publicado: (2021)

Predictive value of pigment epithelial detachment markers for visual acuity outcomes in neovascular age-related macular degeneration
por: Shu, Yiyang, et al.
Publicado: (2023)

Quantification of relative afferent pupillary defect by an automated pupillometer and its relationship with visual acuity and dimensions of macular lesions in age-related macular degeneration
por: Rajan, Renu P, et al.
Publicado: (2021)

Factors for Visual Acuity Improvement After Anti-VEGF Treatment of Wet Age-Related Macular Degeneration in China: 12 Months Follow up
por: Lu, Yan, et al.
Publicado: (2021)

Modelling Cost Effectiveness in Neovascular Age-Related Macular Degeneration: The Impact of Using Contrast Sensitivity vs. Visual Acuity
por: Butt, Thomas, et al.
Publicado: (2014)

Factors affecting visual acuity after one year of follow up after repeated intravitreal ranibizumab for macular degeneration
por: Williams, Gwyn Samuel, et al.
Publicado: (2015)

Neovascular Age‐Related Macular Degeneration: A Visual Acuity Model of Natural Disease Progression and Ranibizumab Treatment Effect
por: Mulyukov, Zufar, et al.
Publicado: (2018)

Evaluating an automated machine learning model that predicts visual acuity outcomes in patients with neovascular age-related macular degeneration
por: Abbas, Abdallah, et al.
Publicado: (2022)

Effect of macular photocoagulation on visual acuity of Omani patients with clinically significant macular edema
por: Zaidi, Zafar A., et al.
Publicado: (2009)

Binocular dynamic visual acuity in dry eye disease patients
por: Ren, Xiaotong, et al.
Publicado: (2023)

Visual Improvement Following Ozonetherapy in Dry Age Related Macular Degeneration; a Review
por: Borrelli, Emma, et al.
Publicado: (2013)

Evaluating Visual Acuity in the American Academy of Ophthalmology IRIS® Registry
por: Brant, Arthur, et al.
Publicado: (2023)

FUSION regimen: ranibizumab in treatment-naïve patients with exudative age-related macular degeneration and relatively good baseline visual acuity
por: Monés, Jordi, et al.
Publicado: (2012)

Key drivers of visual acuity gains in neovascular age-related macular degeneration in real life: findings from the AURA study
por: Holz, Frank G, et al.
Publicado: (2016)

Intravitreal aflibercept for exudative age-related macular degeneration with good visual acuity: 2-year results of a prospective study
por: Sakamoto, Shinichi, et al.
Publicado: (2018)

Relationship Between Rod-Mediated Sensitivity, Low-Luminance Visual Acuity, and Night Vision Questionnaire in Age-Related Macular Degeneration
por: McGuinness, Myra B., et al.
Publicado: (2020)

Correlation between improvement in visual acuity and QOL after Ranibizumab treatment for age-related macular degeneration patients: QUATRO study
por: Oshima, Yuji, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_v45itnmflvt6vovtnu8ib9nlki